Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Effect of Premedication on Pain Perception: functional Magnetic Resonance Imaging (fMRI) study of healthy volunteers
ISRCTN ISRCTN61356305
ClinicalTrials.gov identifier
Public title Effect of Premedication on Pain Perception: functional Magnetic Resonance Imaging (fMRI) study of healthy volunteers
Scientific title A double blind randomised prospective study on the effect of premedication on pain perception: functional magnetic resonance imaging (fMRI) study of healthy volunteers
Acronym PPPMRI
Serial number at source 2008-006826-33
Study hypothesis Premedication reduces pain-related cerebral activation.
Lay summary
Ethics approval Local medical ethics committee (Comité de protection des personnes Ouest II) approved on the 13th March 2009 (ref: 2008-36)
Study design Double blind randomised prospective study
Countries of recruitment France
Disease/condition/study domain Pain perception
Participants - inclusion criteria 1. Informed consent
2. Right handed
3. American Society of Anaesthesiology (ASA) classification I or II
4. No chronic drug therapy
5. No MRI contraindication
6. Accept the interdiction to drive car and drink alcohol until next morning
7. Aged 25 - 65 years, either sex
Participants - exclusion criteria 1. Myasthenia
2. Hypersensibility to midazolam and hydroxyzine
3. MRI contraindication
Anticipated start date 01/12/2009
Anticipated end date 01/12/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 17
Interventions Placebo, hydoxyzine or midazolam ingestion one hour before sequential electrical right forearm pain stimulation and fMRI examination.

The interventions consist of a unique dose ingestion of placebo, hydroxyzine (0.9 mg/kg), and midazolam (0.1 mg/kg) in orange juice, in a randomised design with one week between each session. The follow-up is 6 hours in each arm.
Primary outcome measure(s) Volume of central pain matrix activation on fMRI, obtained by contrasting painful stimulation period with resting state period during fMRI recording.
Secondary outcome measure(s) Visual analogic pain score, measured at the end of each 6 seconds painful stimulation period.
Sources of funding University Hospital Centre of Angers (Centre Hospitalier Universitaire d'Angers) (France)
Trial website
Publications
Contact name Dr  Ter Minassian  Aram
  Address CHU Angers réanimation chirurgicale B
Hôpital Larrey
  City/town Angers
  Zip/Postcode 49993 CEDEX 9
  Country France
  Tel +33 (0)2 41 35 39 51
  Fax +33 (0)2 41 35 52 24
  Email arterminassian@chu-angers.fr
Sponsor University Hospital Centre of Angers (Centre Hospitalier Universitaire d'Angers) (France)
  Address Direction des affaires médicales et de la recherche
  City/town Angers
  Zip/Postcode 49993 CEDEX 9
  Country France
  Tel +33 (0)2 41 35 32 85
  Fax +33 (0)2 41 35 32 89
  Email DAM@chu-angers.fr
  Sponsor website: http://www.chu-angers.fr/
Date applied 28/11/2009
Last edited 12/04/2011
Date ISRCTN assigned 19/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central